Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Asher

Showing results (181-190 of 191) with videos related to

Pageof 20
Sort By:
Frontiers in Cardiovascular Medicine|October 16, 2023
Effect of concurrent mitral valve surgery for secondary mitral regurgitation upon mortality after aortic valve replacement or coronary artery bypass surgeryShyamal R Asher, Chin Siang Ong, Raymond J Malapero, et al.
Scientific Reports|January 3, 2025
Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapyRachael A Potter, Ida H Moeller, Sohrab Khan, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 4, 2013
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed TomographyAllan L Klein, Suhny Abbara, Deborah A Agler, et al.
American Heart Journal|January 3, 2023
Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims dataRobert J Cubeddu, Shannon M E Murphy, Craig R Asher, et al.
Interactive Cardiovascular and Thoracic Surgery|December 14, 2020
Joint preoperative transthoracic and intraoperative transoesophageal echocardiographic assessment of functional mitral regurgitation severity provides better association with long-term mortalityShyamal R Asher, Gregory W Malzberg, Chin Siang Ong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2022
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trialJ S Frenel, J W Kim, N Aryal, et al.
Journal of the American College of Cardiology|September 18, 2020
Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney DiseaseRobert J Cubeddu, Craig R Asher, Ashley M Lowry, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 4, 2009
Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trialJohn A Sallach, Sarinya Puwanant, Jeanne K Drinko, et al.
Neurology and Therapy|January 10, 2026
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK TrialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Nature Medicine|October 9, 2024
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Pageof 20

Showing results (181-190 of 191) with videos related to

Sort By:
Pageof 20
Frontiers in Cardiovascular Medicine|October 16, 2023
Effect of concurrent mitral valve surgery for secondary mitral regurgitation upon mortality after aortic valve replacement or coronary artery bypass surgeryShyamal R Asher, Chin Siang Ong, Raymond J Malapero, et al.
Scientific Reports|January 3, 2025
Immunologic investigations into transgene directed immune-mediated myositis following delandistrogene moxeparvovec gene therapyRachael A Potter, Ida H Moeller, Sohrab Khan, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|September 4, 2013
American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed TomographyAllan L Klein, Suhny Abbara, Deborah A Agler, et al.
American Heart Journal|January 3, 2023
Association of ACEI/ARB and statin prescribing patterns with mortality after Transcatheter Aortic Valve Replacement (TAVR): Findings from real-world claims dataRobert J Cubeddu, Shannon M E Murphy, Craig R Asher, et al.
Interactive Cardiovascular and Thoracic Surgery|December 14, 2020
Joint preoperative transthoracic and intraoperative transoesophageal echocardiographic assessment of functional mitral regurgitation severity provides better association with long-term mortalityShyamal R Asher, Gregory W Malzberg, Chin Siang Ong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2022
Efficacy of subsequent chemotherapy for patients with BRCA1/2-mutated recurrent epithelial ovarian cancer progressing on olaparib versus placebo maintenance: post-hoc analyses of the SOLO2/ENGOT Ov-21 trialJ S Frenel, J W Kim, N Aryal, et al.
Journal of the American College of Cardiology|September 18, 2020
Impact of Transcatheter Aortic Valve Replacement on Severity of Chronic Kidney DiseaseRobert J Cubeddu, Craig R Asher, Ashley M Lowry, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|August 4, 2009
Comprehensive left atrial appendage optimization of thrombus using surface echocardiography: the CLOTS multicenter pilot trialJohn A Sallach, Sarinya Puwanant, Jeanne K Drinko, et al.
Neurology and Therapy|January 10, 2026
Two-Year Outcomes Following Delandistrogene Moxeparvovec Treatment in Ambulatory Patients with Duchenne Muscular Dystrophy: Phase 3 EMBARK TrialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Nature Medicine|October 9, 2024
AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trialJerry R Mendell, Francesco Muntoni, Craig M McDonald, et al.
Pageof 20